A randomised joint Australasian (ALLG) and French (FILO) study of lenalidomide consolidation in patients with residual CLL after front-line treatment with FC/FCR (the CLL6 Trial)
Research output: Contribution to journal › Meeting Abstract › peer-review
Fingerprint
Dive into the research topics of 'A randomised joint Australasian (ALLG) and French (FILO) study of lenalidomide consolidation in patients with residual CLL after front-line treatment with FC/FCR (the CLL6 Trial)'. Together they form a unique fingerprint.
Medicine and Dentistry
Pharmacology, Toxicology and Pharmaceutical Science